Immunosuppressive Agents: all 5,940 studies that test it

Page 31 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyStatus unknownNCT04376528Phase 4
• Sirolimus in COVID-19 Phase 1WithdrawnNCT04371640Phase 1
• Leflunomide for the Treatment of High-Risk Smoldering Multiple MyelomaActive, not recruitingNCT04370483Early Phase 1
• Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and TrismusActive, not recruitingNCT04365088Phase 4
• Steroid Injection for Adhesive CapsulitisStatus unknownNCT04364425Not applicable
• Reduced Intensity Transplantation for Severe Sickle Cell DiseaseActive, not recruitingNCT04362293Phase 2
• Leflunomide in Mild COVID-19 PatientsTerminatedNCT04361214Phase 1
• Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in SpondyloarthritisCompletedNCT04360785Not applicable
• Molecularly Targeted Umbrella Study in Luminal Advanced Breast CancerStatus unknownNCT04355858Phase 2
• Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 PatientsStatus unknownNCT04352465Phase 1/2
• Impact of T Cells on Age-related Vascular Dysfunction: A Translational ApproachWithdrawnNCT04344873Early Phase 1
• Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract SurgeryCompletedNCT04342988Phase 4
• Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung InjuryStatus unknownNCT04341038Phase 3
• Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCLStatus unknownNCT04337593Phase 2
• NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 3
• Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for KeloidStatus unknownNCT04326959Phase 1/2
• Sirolimus Combined With ATRA for the Treatment of Auto-Immune AnemiaWithdrawnNCT04324411Phase 4
• Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell LymphomaActive, not recruitingNCT04323956Phase 1
• "Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT04317248Phase 2
• Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary SarcoidosisActive, not recruitingNCT04314193Phase 4
• The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic PregnancyStatus unknownNCT04308343Not applicable
• Tetrandrine Tablets Used in the Treatment of COVID-19Status unknownNCT04308317Phase 4
• Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast CancerActive, not recruitingNCT04290793Phase 2/3
• Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHDStatus unknownNCT04289103Phase 3
• CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWithdrawnNCT04282174Phase 2
• Fingolimod in COVID-19WithdrawnNCT04280588Phase 2
• The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19Status unknownNCT04273581Phase 2
• The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) PneumoniaStatus unknownNCT04273529Phase 2
• A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677CompletedNCT04268394Phase 1
• Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic MalignanciesStatus unknownNCT04264078Early Phase 1
• A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.WithdrawnNCT04263519Phase 2
• Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
• The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell CarcinomaStatus unknownNCT04262427Phase 1/2
• Effect of Zilretta InjectionCompletedNCT04261049Phase 1
• Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory ArthritisTerminatedNCT04261023Phase 2
• Understanding GWI: Integrative ModelingStatus unknownNCT04255498Phase 1
• Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)CompletedNCT04255134Phase 4
• Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLStatus unknownNCT04254640Phase 2
• TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis ResetCompletedNCT04254627Phase 1
• Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)Status unknownNCT04247750Phase 2
• Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and BortezomibTerminatedNCT04243109Phase 2
• Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver TransplantsCompletedNCT04237246Phase 4
• Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive VitiligoCompletedNCT04237103Phase 2
• Effect of the Cervical Interlaminar Epidural Steroid Injection on Quality of Life, Pain and DisabilityStatus unknownNCT04235478Not applicable
• Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell LymphomaActive, not recruitingNCT04231877Phase 1/2
• ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHDTerminatedNCT04227938Phase 1
• Deflazacort Vs. Prednisolone in Acute-stage ABPAActive, not recruitingNCT04227483Phase 2/3
• Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast CancerCompletedNCT04224922Phase 2
• Golimumab for the Treatment of Refractory Behcet's UveitisTerminatedNCT04218565Phase 2
• CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT04214886Phase 1
• DCV in the Treatment of Recurrence and Refractory Childhood Solid TumorsStatus unknownNCT04213612Phase 1
• Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host DiseaseActive, not recruitingNCT04212416Phase 1
• Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity EffectsActive, not recruitingNCT04207177Phase 4
• Abatacept for Treatment of Recurrent or de Novo Autoimmune HepatitisTerminatedNCT04203875Phase 1
• ATG in HLA-matched Sibling HSCT as GVHD ProphylaxisStatus unknownNCT04203108Phase 4
• ATG Plus PTCy vs ATG for CGVHD ProphylaxisActive, not recruitingNCT04202835Phase 2
• Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid NeoplasmsTerminatedNCT04196010Phase 1
• Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-CancerCompletedNCT04187898Phase 1
• A MolEcularly Guided Anti-Cancer Drug Off-Label TrialActive, not recruitingNCT04185831Phase 2
• Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for InjectionStatus unknownNCT04178850Phase 3
• Cladribine Tablets After Treatment With Natalizumab (CLADRINA)Active, not recruitingNCT04178005Phase 4
• Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT04173988Early Phase 1
• Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 DaysStatus unknownNCT04172961Phase 4
• Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary DiseaseActive, not recruitingNCT04166565Phase 2
• The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive DepressionStatus unknownNCT04156425Not applicable
• Autologous Transplant Targeted Against Crohn'sWithdrawnNCT04154735Phase 2
• Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy SubjectsCompletedNCT04152759Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese SubjectsCompletedNCT04143477Phase 1
• Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple SclerosisCompletedNCT04129736Phase 4
• TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUNCompletedNCT04128722Phase 2
• A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04123795Phase 3
• Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)CompletedNCT04121403Phase 3
• TOLERA: Tolerance Enhancement in RAStatus unknownNCT04120831Phase 2
• Early Markers of Disease and Response to TherapyCompletedNCT04118153Early Phase 1
• Liposomal Sirolimus in Dry Eye DiseaseCompletedNCT04115800Early Phase 1
• Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)CompletedNCT04114188Phase 2
• Abatacept Bone Effects in Psoriatic Arthritis With Bone BiomarkerStatus unknownNCT04106804Phase 4
• Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.CompletedNCT04102943Phase 4
• Non-Viral TCR Gene TherapyWithdrawnNCT04102436Phase 2
• Sirolimus for Cowden Syndrome With Colon PolyposisCompletedNCT04094675Phase 2
• Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff DiseaseActive, not recruitingNCT04094298Phase 3
• T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)WithdrawnNCT04093648Phase 1
• A Phase 2 Trial for Men With Metastatic Prostatic AdenocarcinomaCompletedNCT04090775Phase 2
• Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast CancerActive, not recruitingNCT04083963Phase 2
• Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and EnbrelStatus unknownNCT04079374Phase 3
• Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDsStatus unknownNCT04077957Phase 4
• Safety and Efficacy of Low-dose Sirolimus to Kaposiform HemangioendotheliomaCompletedNCT04077515Phase 4
• Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple TherapyWithdrawnNCT04075136Phase 4
• TNF-α Treatment of Blast-Induced TinnitusActive, not recruitingNCT04066348Phase 2
• Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic SyndromeCompletedNCT04048161Phase 4
• Study of Sirolimus in Idiopathic Retroperitoneal FibrosisCompletedNCT04047576Phase 2/3
• Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)TerminatedNCT04039347Phase 3
• COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
• CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.Status unknownNCT04037566Phase 1
• Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas DiseaseActive, not recruitingNCT04024163Phase 3
• Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain TumorsCompletedNCT04023669Phase 1
• Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal InsufficiencyStatus unknownNCT04020328Phase 4
• Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
• Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical StudyCompletedNCT04009525Phase 4
• Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia AreataStatus unknownNCT04003376Phase 4

← Immunosuppressive Agents overview